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Introduction 
 
During the past few decades increasing interest in the synthesis and properties of 
pyridazines, pyridazinones, pyridopyridazines, and pyridopyridazinones has been 
observed.  
Pyridopyridazines and pyridopyridazinones show wide spectrum of biological activities 
as described in the literature [1-4]. Both classes of substances are of interest as antiviral 
and cancer therapies, since their structures and properties resemble those of certain 
current pteridines and purines. 
Recently pyridazinone nucleus has been extensively studied in the search for new and 
selective medicinal agents as drugs acting on the cardiovascular system [5,6]. It has 
been discovered that several aminopyridazinones showed remarkable biological 
activities; for example, nootropic (memory-improving) [7]. 
In contrast to the phthalazinones, their aza analogs, pyridopyridazinones, are as yet 
relatively little studied their synthesis, chemical properties and further applications. The 
primary reasons for this are the difficulties associated with the preparation of pyridine 
starting materials which can easily be transformed into pyridopyridazinones. The only 
general method for the synthesis of the system pyridopyridazinones involves the 
cyclization of o-acylpyridinecarboxylic acids [8] and their derivatives (ester [8] and 
disubstitute amides [9] or of methyl esters of o-cyanopyridinecarboxylic acids [10] with 
hydrazine and monosubstituted hydrazines). 
Continuing our interest on the synthesis of pyridazinones [11,12] we present in this 
work their synthesis applying a method which was previously employed in only a few 
cases to the preparation of pyridazinones [13]. 
 
Results and Discussion 
The literature showed that, preparation of compounds 1 and 2 could be obtained from 
cyclocondensation of arylhydrazonomalononitriles with malononitrile, 2-amino-1,1,3-
tricycanopropene, and 3-amino-2-cyanopent-2-ene dicarboxylate [14], [15] respectively 
(Scheme 1). 
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It was decided to build compounds of type 1 and 2 by both routes, from the reaction of 
3-methoxyphenyl hydrazonomalononitrile with two equivalents of malononitrile (MN) 
and from coupling of arene diazonium chloride with 2-amino-1,1,3-tricycanopropene 
(MND), and 3-amino-2-cyanopent-2-ene dicarboxylate (ethyl or methyl cyano dimmer) 
to obtain pyridazine derivatives and further reaction of the latter with another mole of 
MN to obtain the desired products and confirm the way of cyclization of those 
compounds when reacted with MN. 
 
The reaction of compound 4a (MND), with aryldiazonium chlorides followed by 
cyclization in ethanolic triethylamine afforded the pyridazinimine derivatives 8a,b. 
Reaction of compounds 8a,b with another mole of malononitrile could takes place in 
two different pathways to afford pyrido[3,2-c]pyridazine or pyrido[2,3-d]pyridazine 
derivatives. 
 
It was found that the reaction of pyridazine derivatives 8a,b with malononitrile afforded 
1a,b in a good yield. Compound 1a,b could also be obtained from the reaction of 7a,b 
with malononitrile under refluxing in ethanolic triethylamine solution for 4 h. The data 
in our hands, IR, mass, 1H and 13C NMR, are in accordance with the structure of 
pyrido[3,2-c] pyridazines 1 [15, cf. experimental part] (Scheme 2). 
Moreover, the presence of an NOE enhancement between the NH group and CH 
aromatic protons in structure 1 and the absence of an NOE between NH and NH2 group 
for structure 2 allowed establishing the structure 1. 
 
The reaction of 2-(1-amino-2-cyanoethylidene)malonic acid diethyl 4b or dimethyl 4c 
ester and 4-chlorobenzene diazonium chloride to afford the hydrazo derivative 11a,b 
which could be cyclised into pyridazinone 12a,b. The reaction of compounds 12a,b 
with malononitrile produce only pyridazine-3-carboxylic acid 13 which could also be 
obtained by boiling of compound 11 in ethanolic triethylamine solution for long time to 
furnish 13 (Scheme 2). 
 
Experimental 
All melting points were measured on a Gallenkamp apparatus and are uncorrected. IR 
spectra were determined on a Perkin Elmer FTIR-1600 using Nujol emulsions between 
NaCl plates. 1HNMR spectra were recorded at 300 MHz and 13C NMR spectra were 
determined at 75.4 MHz both on Varian Unity plus spectrometer. In the NMR spectra 
was used TMS as internal reference. Low resolution EI mass spectra were determined 
on a Unicam GC-MS 120. FAB or high resolution mass spectra were obtained on a VG 
Ultima or AutoSpec E spectrometers. Elemental analysis data were obtained on a Leco 
CHNS-932. 
 
General procedure for the preparation of compounds 8a,b and 12a,b 
To a solution of each of 7a,b and 11a,b (10 mmol) in ethanol (25 ml) was added 
triethylamine (1ml). The reaction mixture was refluxed for 2-6 h, then allowed to cool, 
the precipitated solid products formed were collected by filtration, washed with cold 
water, and recrystalized from ethanol or ethanol/DMF (1:1) to afford 8a,b and 13a,b 
respectively. 
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4-Amino-6-imino-1-(3-methoxyphenyl)-1,6-dihydro-pyridazine-3,5-dicarbonitrile 
(8a). Red powder, Yield 92 %, mp > 300oC ethanol/DMF (1:1), 1H NMR (300 MHz, 
DMSO-d6) δ, 3.77 (s, 3H, CH3), 7.04-7.08 (m, 3H, Ar-H), 7.41-(s, 1H, NH), 7.43 (s, 
1H, Ar-H), 7.48 (br, 2H, NH2). Anal. Calcd. for (C13H10N6O): C, 58.64; H, 3.79; N, 
31.56. Found C, 58.51, H, 4.01, N, 30.99. 
4-Amino-1-(4-chlorophenyl)-6-imino-1,6-dihydro-pyridazine-3,5-dicarbonitrile 
(8b). Red powder, Yield 90 %, mp > 300oC ]Lit. mp mp > 300oC 16], ethanol/DMF 
(1:1), 1H NMR (300 MHz, DMSO-d6) δ, 6.82 (s, 1H, NH), 7.7 (d, 2H, J = 9 Hz, Ar-H), 
7.99 (d, 2H, J = 9 Hz, Ar-H), 8.68 (s, 2H, NH2). 
 
4-Amino-1-(4-chloro-phenyl)-5-cyano-6-oxo-1,6-dihydro-pyridazine-3-carboxylic 
acid ethyl ester (12a) 
Yellow powder, Yield 92 %, mp 290-292oC ethanol/DMF (1:1), MS (EI), m/z = 318 
[M+, 24.8 %], 320 [(M+2)+, 5 %] 
1H NMR (300 MHz, DMSO-d6) δ, 1.26 (t, 3H, J = 7Hz, CH3), 4.33 (q, 2H, J = 7Hz, 
CH2), 7.51-7.60 (m, 4H, Ar-H), 8.20 (brs, 2H, NH2). 
 
4-Amino-1-(4-chloro-phenyl)-5-cyano-6-oxo-1,6-dihydro-pyridazine-3-carboxylic 
acid methyl ester (12b) 
Yellow powder, Yield 80 %, mp 279-280oC ethanol/DMF (1:1),  
1H NMR (300 MHz, DMSO-d6) δ, 3.83 (s, 3H, CH3), 7.51-7.60 (m, 4H, Ar-H), 8.10 (s, 
1H, NH), 8.42 (s, 1H, NH). 
Anal. Calcd. for (C13H9ClN4O3): C, 51,25; H, 2,98; N, 18,39. Found C, 51.24; H, 3.03; 
N, 18.39. 
General procedure for preparation of compounds 1a,b 
To a solution of each of 7a,b and 8a,b (10 mmol), malononitrile (10 mmol) in ethanol 
(25 ml) was added triethylamine (1ml). The reaction mixture was refluxed for 3 h, then 
allowed to cool, the precipitated solid products formed were collected by filtration, 
washed with ethanol, and recystalized from ethanol/DMF (1:2) to afford 1a,b 
 
6,8-Diamino-3-imino-2-(3-methoxyphenyl)-2,3-dihydropyrido[3,2-c]pyridazine-4,7-
dicarbonitrile (1a) 
Red powder, Yield 94 %, mp > 300oC ethanol/DMF (1:1), (Lit. mp > 360oC, 15), IR, 
2217 (CN), 3355, 3457(NH, NH2)   
1H NMR (300 MHz, DMSO-d6) δ, 3.79 (s, 3H, CH3), 6.29 (brs, 1H, NH, exchangeable 
D2O), 7.03 (dd, 1H, J = 9 Hz, 2.1 Hz, Ar-H), 7.15 (m, 2H, Ar-H), 7.43 (t, 1H, J = 9Hz, 
Ar- H), 7.63 (brs, 1H, NH, exchangeable D2O), 8.08 (s, 2H, NH2, exchangeable D2O), 
8.26 (brs, 1H, NH, exchangeable D2O). 
13C NMR (75.4 MHz, DMSO-d6) δ  56.4 (CH3), 70.9 (C-7), 89.8 (C-4), 112.4 (C-2´), 
114.7 (CN), 114.8 (C-4´), 115.9 (CN), 118.5 (C-6´), 126.2 (C-9), 129.8 (C-5´), 141.8 
(C-1´), 148.9 (C-9a), 154.3 (C-3), 155.4 (C-8), 159.7 (C-3´), 161.4 (C-6). 
MS (FAB) m/z 333 (M+ + 1, 100%), 
Anal. Calcd. for (C16H12N8O): C, 57.83; H, 3.64; N, 33.72. Found C, 57.49, H, 4.02, N, 
33.95. 
6,8-Diamino-2-(4-chlorophenyl)-3-imino-2,3-dihydropyrido[3,2-c]pyridazine-4,7-
dicarbonitrile (1b) 
Red powder, Yield 90 %, mp > 300oC ethanol/DMF (1:1), 1H NMR (300 MHz, DMSO-
d6) δ, 6.50 (s, 1H, NH), 7.57 (d, 2H, J = 9 Hz, Ar-H), 7.68 (d, 2H, J = 9 Hz, Ar-H), 
7.69(s, 1H, NH), 8.10 (s, 2H, NH2), 7.69, 8.29 (s, 1H, NH). 
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4-Amino-1-(4-chlorophenyl)-5-cyano-6-oxo-1,6-dihydro-pyridazine-3-carboxylic 
acid 13 
To a solution of each of 11a,b and 12a,b (10 mmol) in ethanol (25 ml) was added 
triethylamine (1ml). The reaction mixture was refluxed for 7 h, then allowed to cool, the 
precipitated solid product formed was collected by filtration, washed with ethanol, and 
recystalized from ethanol/DMF (1:1) to afford 13. 
Reddish brown powder, mp 244-246oC (EtOH), in  74% yield.  
1H NMR (300 MHz, DMSO-d6) δ, 7.52 (m, 5H, 4Ar-H, 1H, NH), 8.16 (s, 1H, NH), 
10.47 (s, 1H, COOH). 
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